Association between immune-related adverse events and clinical outcomes in advanced genitourinary cancers treated with immunotherapy: A systematic review and meta-analysis

被引:0
|
作者
Chen, J. [1 ]
Zhang, Y. [1 ]
Ni, Y. [1 ]
Sun, G. S. [1 ]
Zeng, H. [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Urol, Chengdu, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A0386
引用
收藏
页码:S598 / S598
页数:1
相关论文
共 50 条
  • [31] Use of immune checkpoint inhibitors and risk of immune-related adverse events among patients with advanced melanoma: A systematic review and network meta-analysis
    Chang, Ching-Yuan
    Wang, Ching-Yu
    Park, Haesuk
    Lo-Ciganic, Wei-Hsuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 472 - 473
  • [32] Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Zhang, Wei
    Tan, Yifei
    Li, Yuquan
    Liu, Jiang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
    Zhou, Xiaoxiang
    Yao, Zhuoran
    Yang, Huaxia
    Liang, Naixin
    Zhang, Xuan
    Zhang, Fengchun
    BMC MEDICINE, 2020, 18 (01)
  • [34] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    ONCOLOGIST, 2023, : 1072 - 1078
  • [35] The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Machado, Antonio Pizuorno
    Afifi, Ahmed M.
    Ratliff, Hunter
    Vohra, Muhammad H.
    Kuang, Andrew
    Shatila, Malek
    Khan, Muhammad Ali
    Thomas, Anusha
    Philpott, Jessica
    Alhalabi, Omar
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1266 - S1267
  • [36] A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma
    Wang, Bengang
    Hao, Xiangjun
    Yan, Jinshan
    Li, Xin
    Zhao, Mingfang
    Han, Tao
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2024, 12 (03) : 225 - 243
  • [37] Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
    Xiaoxiang Zhou
    Zhuoran Yao
    Huaxia Yang
    Naixin Liang
    Xuan Zhang
    Fengchun Zhang
    BMC Medicine, 18
  • [38] Immune-related adverse events in advanced NSCLC treated with immunotherapy alone or concurrent chemotherapy and immunotherapy.
    Melson, John
    Reed, Daniel
    Horton, Bethany J.
    Moore, Margaret
    Brown, Jacqueline Theresa
    Gentzler, Ryan D.
    Hall, Richard Delmar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [39] Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO plus IPI: a systematic review and meta-analysis
    Xing, Puyuan
    Zhang, Fan
    Wang, Guoqiang
    Xu, Yu
    Li, Chengcheng
    Wang, Shouzheng
    Guo, Yiying
    Cai, Shangli
    Wang, Yan
    Li, Junling
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [40] Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis
    Hossein Azadeh
    Reza Alizadeh-Navaei
    Alireza Rezaiemanesh
    Misagh Rajabinejad
    Inflammopharmacology, 2022, 30 : 435 - 451